Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00136084 · ClinicalTrials.gov registry record · Phase 3
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
A Phase 3 study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 238
- Enrollment target
NCT00136084: Completed Phase 3 study, sponsored by St. Jude Children's Research Hospital.
NCT00136084 is a Phase 3 study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 238 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00136084, a Phase 3 study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of two multi-agent chemotherapy regimens using different dosages of cytarabine to eliminate all detectable leukemia.
Primary Outcome
Detection of Minimal Residual Disease following one course of chemotherapy where positive MRD was defined as one or more leukemic cell per 1000 mononuclear bone-marrow cells (\>=0.1%).
Interventions
- DRUG Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone
- DRUG Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2002-08 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT00136084 record still lists
NCT00136084 is an interventional study that assigns participants to a tested intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone is the first listed.
NCT00136084 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00136084 about?
NCT00136084 is a clinical study titled "Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia". The purpose of this study is to compare the effectiveness of two multi-agent chemotherapy regimens using different dosages of cytarabine to eliminate all detectable leukemia.
What is the current status of trial NCT00136084?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 238 participants. The study started on 2002-08. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00136084?
The interventions under investigation include: Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone (DRUG), Etoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine (DRUG).
Who is sponsoring clinical trial NCT00136084?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00136084's enrollment target sits among peer trials
238 1291st of 2000 higher than 708 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia